Email this article VALUE OF GENDER’S RATIO FOR INTEGRITY ETHICAL AND SCIENTIFIC STANDARDS IN CLINICAL TRIALS
- Authors: Kubar O.I1,2
-
Affiliations:
- Saint - Petersburg Pasteur Institute
- UNESCO
- Issue: Vol 9, No 1 (2016)
- Pages: 21-24
- Section: Articles
- URL: https://ogarev-online.ru/2070-1586/article/view/54981
- ID: 54981
Cite item
Full Text
Abstract
This article has stressed on actual problem to take into consideration the gender's ratio in clinical trials for following the ethical principles and maintain data quality. It is shown that the essential different in medications activity are depended from gender factors. Bioethical and gender indexes have been companied at the different phases of planning the study, selecting the participants and conducting clinical trials. In article is presented that the data of gender's ratio in R&D of medications dose should be available and the evaluation of pharmacological features of drug necessary to make in clinical trials where gender balance of participants take place. All potential problems of gender balance connected with cultural, religion and social - economic factors. There are the specific of gender's behavior for different groups of participants what influence on following ethical standards in the process of obtaining and documenting informed consent. Subject protection and the collecting of relative data requires the transparency of gender's ratio concerning with trial's participants.
Full Text
##article.viewOnOriginalSite##About the authors
O. I Kubar
Saint - Petersburg Pasteur Institute; UNESCO
Email: okubar@list.ru
PhD, leading scientific researcher, laboratory for etiology and control of viral infections; member IBC Saint - Petersburg
References
- Доника А.Д. Медицинское право: европейские традиции и международные тенденции // Биоэтика. № 2(10). 2012. С. 54 - 55.
- Доника А.Д. Проблема формирования этических регуляторов профессиональной деятельности врача // Биоэтика. 2015. № 1(15). С. 58 - 60.
- Иванов Д.Д., Шупика П.Л. Гендерные особенности в доказательной медицине // Медицинские аспекты здоровья женщины. - 2011. - № 3 (42). - С. 21 - 23
- Методические указания: Проведение качественных исследований биоэквивалентности лекарственных средств // Минздравсоцразвития РФ: Методические указания. - 2004. - 18 с.
- Оленко Е.С., Кодочигова А.И., Киричук В.Ф., Субботина В.Г., Сушкова Н.В. Гендерная специфика особенностей личности у здоровых заключенных // Бюллетень медицинских интернет - конференций (БМИК) - 2011. - Т. 1. - № 7. - С. 48 - 51.
- Седова Н.Н. Все законы когда - то были нормами морали, но не все моральные нормы становятся законами // Биоэтика. - 2009. - № 1(3) - С.37 - 40.
- AHRQ Publication No. 11 - P003 (Replaces AHRQ Publication No. 09 - PB005), Current as of December 2010
- Arda B., Rispler - Chaim V. Islam and Bioethics: Ankara, Turkey. - 2011. - 268.
- Convention on the Elimination of All Forms of Discrimination against Women: General Assembly Resolution A/RES/34/180. New York 1979;
- General Assembly Resolution A/RES/54/4United Nations. New York. 1999
- ptowsky A.R., McWilliams J.V., Cannon C.P. Aspirin for Heart Disease and Stroke Reduction: Men vs. Women // J Gen Intern Med 22: 5561, 2007 (AHRQ grant T32 HS00020)
- Universal Declaration on Bioethics and Human Rights, UNESCO: Paris. - 2005
- Universal Declaration of Human Rights, UN. - 1948
Supplementary files
